Literature DB >> 24731756

Should sleep laboratories have their own predictive formulas for continuous positive airway pressure for patients with obstructive sleep apnea syndrome?

Ming-Feng Wu1, Jeng-Yuan Hsu2, Wei-Chang Huang3, Gwan-Han Shen2, Jiunn-Min Wang4, Chih-Yu Wen5, Kang-Ming Chang6.   

Abstract

BACKGROUND: Several formulas predicting optimal continuous positive airway pressure (CPAP) for obstructive sleep apnea treatment have been developed and diverse parameters selected as predictive factors in different sleep laboratories using different ethnic groups. This study aimed to validate a constructed predictive formula for the study laboratory and to test the hypothesis that sleep laboratories should have their own predictive formulas.
METHODS: Fifty-seven adult subjects with obstructive sleep apnea syndrome (OSAS) were enrolled in the model-building set and underwent two polysomnography (PSG) studies to diagnose OSAS and titrate for optimal CPAP. A predictive formula, derived from anthropometric and polysomnographic variables, was validated together with two other predictive formulas in 30 subjects by comparing the mean predictive CPAP values, rates of successful prediction, and agreements.
RESULTS: Regression analysis showed that apnea-hypopnea index (AHI), SaO2nadir (nadir of arterial oxyhemoglobin saturation by pulse oximetry), and body mass index (BMI) strongly correlated with optimal CPAP. The derived predictive formula for the study laboratory was: CPAPpred (predictive CPAP) = 6.380 + 0.033 × AHI - 0.068 × SaO2nadir + 0.171 × BMI (R(2) = 0.335, adjusted R(2) = 0.298). In Taiwan, different predictive formulas used by different sleep laboratories with different independent predictors led to similar mean predictive CPAP values to the mean observed optimal CPAP values, rates of successful prediction, and agreements with the observed optimal CPAP. There were significant differences between the mean predictive CPAP values and mean observed optimal CPAP values, lower rates of successful prediction, and negatively skewed 95% confidence interval (CI) when using a predictive formula derived from different ethnic populations.
CONCLUSION: A sleep laboratory may not need to have its own predictive formula for determining the optimal effective CPAP but should adopt the one derived from the same ethnicity of OSAS patients as the reference formula.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  continuous positive airway pressure; obstructive sleep apnea syndrome; predictive formula

Mesh:

Year:  2014        PMID: 24731756     DOI: 10.1016/j.jcma.2014.02.015

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  5 in total

1.  A new predictive model for continuous positive airway pressure in the treatment of obstructive sleep apnea.

Authors:  Matthew R Ebben; Mariya Narizhnaya; Ana C Krieger
Journal:  Sleep Breath       Date:  2016-11-22       Impact factor: 2.816

2.  Different Continuous Positive Airway Pressure Titration Modalities in Obstructive Sleep Apnea Syndrome Patients.

Authors:  Hadeer Ahmed Elshahaat; Tarek Abd El-Hakeem Mahfouz; Ashraf Elsyed Elshora; Amany Shaker
Journal:  Int J Gen Med       Date:  2021-12-21

3.  A predictive model for optimal continuous positive airway pressure in the treatment of pure moderate to severe obstructive sleep apnea in China.

Authors:  Le Wang; Xing Chen; Dong-Hui Wei; Mao-Li Liang; Yan Wang; Bao-Yuan Chen; Jing Zhang; Jie Cao
Journal:  BMC Pulm Med       Date:  2022-06-16       Impact factor: 3.320

Review 4.  Mathematical Equations to Predict Positive Airway Pressures for Obstructive Sleep Apnea: A Systematic Review.

Authors:  Macario Camacho; Muhammad Riaz; Armin Tahoori; Victor Certal; Clete A Kushida
Journal:  Sleep Disord       Date:  2015-07-30

5.  Determination of equation for estimating continuous positive airway pressure in patients with obstructive sleep apnea for the Indian population.

Authors:  Latha Sarma; Nandan Putti; Kapil Alias; Mohit Chilana
Journal:  Lung India       Date:  2020 Sep-Oct
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.